Merck & Co., Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Merck & Co., Inc. (MRK) had Operating Leases, Future Minimum Payments, Due in Two Years of $198.00 million as of 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $198.00M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $175.00M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $141.00M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $136.00M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $198.00M 10-K · filed 2020-02-26 |
| 2017-12-31 | $175.00M 10-K · filed 2018-02-27 |
| 2016-12-31 | $141.00M 10-K · filed 2017-02-28 |
| 2015-12-31 | $136.00M 10-K · filed 2016-02-26 |
| 2014-12-31 | $122.00M 10-K · filed 2015-02-27 |
| 2013-12-31 | $208.00M 10-K · filed 2014-02-27 |
| 2012-12-31 | $172.00M 10-K · filed 2013-02-28 |
| 2011-12-31 | $157.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |